We are live on ! Find out more
ACM

Altium Capital Management Portfolio holdings

AUM $42M
This Fund
S&P 500
This Quarter Est. Return
+23.6%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$147M
AUM Growth
-$44.4M
Cap. Flow
-$65.4M
Cap. Flow %
-44.37%
Top 10 Hldgs %
60.34%
Holding
94
New
22
Increased
8
Reduced
10
Closed
28

Top Buys

Rank Stock Value
1
BOXX icon
Alpha Architect 1-3 Month Box ETF
BOXX
+$9.68M
2
CPRX
Catalyst Pharmaceutical
CPRX
+$5.26M
3
SVRA icon
Savara
SVRA
+$5.11M
4
VERA icon
Vera Therapeutics
VERA
+$3.57M
5
INSM icon
Insmed
INSM
+$3.11M

Top Sells

Rank Stock Value
1
CBAY
Cymabay Therapeutics
CBAY
+$12.3M
2
IMGN
Immunogen Inc
IMGN
+$11.5M
3
GPCR icon
Structure Therapeutics
GPCR
+$7.82M
4
BHVN icon
Biohaven
BHVN
+$7.46M
5
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$6.36M

Sector Composition

Rank Sector Weight
1 Healthcare 88.88%
2 Communication Services 0.3%
3 Industrials 0.07%
4 Consumer Staples 0.05%
5 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CINGW icon
51
Cingulate Inc Warrants
CINGW
$33.2K
$8.1K 0.01%
270,000
– –
BTMWW
52
DELISTED
Bitcoin Depot Inc Warrant
BTMWW
$7.25K ﹤0.01%
50,000
– –
CDTTW
53
CDT Equity Inc Warrant
CDTTW
$1.87M
$6.93K ﹤0.01%
100,000
– –
OSAAW
54
DELISTED
ProSomnus, Inc. Warrant
OSAAW
$4.26K ﹤0.01%
150,000
– –
VSEEW
55
VSEE HEALTH INC WTS 29
VSEEW
$3.91K ﹤0.01%
150,000
– –
CYCUW
56
Cycurion Inc Warrant
CYCUW
$311K
$3.19K ﹤0.01%
100,000
– –
BNCWW
57
CEA Industries Inc Warrant
BNCWW
$2.99K ﹤0.01%
250,000
– –
TGVCW
58
DELISTED
TG Venture Acquisition Corp. Warrants
TGVCW
$2.96K ﹤0.01%
200,000
– –
NEXRW
59
Nexera Technologies Ltd Warrant
NEXRW
$48.9K
$2.59K ﹤0.01%
68,681
-412,089
-86% -$11.6K
SRZNW icon
60
Surrozen Inc Warrant
SRZNW
$8.86K
$1.44K ﹤0.01%
82,233
– –
MITAW
61
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$1.13K ﹤0.01%
28,333
– –
NXLIW
62
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$924 ﹤0.01%
105,000
– –
TCBPW
63
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$612 ﹤0.01%
18,823
– –
SLNAW
64
DELISTED
Selina Hospitality PLC Warrant
SLNAW
$426 ﹤0.01%
101,439
– –
BRSHW
65
DELISTED
Bruush Oral Care Inc. Warrant
BRSHW
$98 ﹤0.01%
14,423
– –
ABOS icon
66
Acumen Pharmaceuticals
ABOS
$176M
– –
-650,000
Closed -$2.7M
ACRS icon
67
Aclaris Therapeutics
ACRS
$825M
– –
-403,000
Closed -$2.76M
ACRS icon
68
PUT
Aclaris Therapeutics
ACRS
$825M
– –
-175,000
Closed -$1.2M
APLS
69
PUT
DELISTED
Apellis Pharmaceuticals
APLS
– –
-100,000
Closed -$3.8M
AVXL icon
70
CALL
Anavex Life Sciences
AVXL
$310M
– –
-154,900
Closed -$1.01M
AVXL icon
71
PUT
Anavex Life Sciences
AVXL
$310M
– –
-154,900
Closed -$1.01M
BHVN icon
72
Biohaven
BHVN
$2.21B
– –
-287,000
Closed -$7.46M
COGT icon
73
Cogent Biosciences
COGT
$7.24B
– –
-235,000
Closed -$2.29M
DYN icon
74
Dyne Therapeutics
DYN
$4.9B
– –
-315,000
Closed -$2.82M
GPCR icon
75
Structure Therapeutics
GPCR
$3.78B
– –
-155,000
Closed -$7.82M
1 2
3
4

Similar funds

TA
TLS Advisors Miami, Florida $42.1M AUM 25.99% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
SCM
Stadium Capital Management New Canaan, Connecticut $40.6M AUM 5.83% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return

Altium Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Altium Capital Management held 94 positions worth $147M, down 23% from $192M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Altium Capital Management withdrew a net $65.4M in Q4 2023, closing 28 positions and reducing 10 holdings. Its most notable exit was Immunogen Inc, an estimated $11.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 88% a quarter earlier, followed by Communication Services and Industrials.

Against the trend, Altium Capital Management opened a new position in Alpha Architect 1-3 Month Box ETF worth $9.75M.

  • Altium Capital Management's largest Q4 2023 buy was Alpha Architect 1-3 Month Box ETF: 92,700 shares worth $9.75M.
  • Altium Capital Management added most to Vera Therapeutics in Q4 2023, an estimated $3.57M increase.
  • Altium Capital Management's biggest Q4 2023 reduction was Cymabay Therapeutics, cutting an estimated $12.3M.
  • Altium Capital Management fully exited Immunogen Inc in Q4 2023, selling an estimated $11.5M.
  • Altium Capital Management's ten largest holdings make up 60% of its $147M portfolio in Q4 2023.
  • Altium Capital Management opened 22 new positions and closed 28 in Q4 2023.
  • Altium Capital Management's portfolio value fell 23% quarter-over-quarter to $147M.

Based on Altium Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.